1. The preclinical pharmacological profile of WAY-132983, a potent M1 Preferring Agonist;Bartolomeo;Journal of Pharmacology and Experimental Therapeutics,2000
2. On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis;Bartus;Experimental Neurology,2000
3. SIB-1553A, (±)-4-{[2-(1-methyl-2-pyrrolidinyl)ethyl]thio}phenol hydrochloride, a subtype-selective ligand for nicotine acetylcholine receptors with putative cognitive-enhancing properties: Effects on working and reference memory performances in aged rodents and non-human primates;Bontempi;Journal of Pharmacology and Experimental Therapeutics,2001
4. Cognitive effects of nicotinic cholinergic agonists in non-human primates;Buccafusco;Drug Development Research,1996
5. Differential improvement in memory-related task performance to nicotine by aged male and female rhesus monkeys;Buccafusco;Behavioral Pharmacology,1999